¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÃé´ãµµÇÐȸ 2019³â Ãá°èÇмú´ëȸ : 2019-04-27

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÃé´ãµµÇÐȸ 2019³â Ãá°èÇмú´ëȸ : 2019-04-27
±³À°ÀÏÀÚ : 2019-04-27
±³À°Àå¼Ò : ¿©Àǵµ ÄÜ·¡µå È£ÅÚ, ±×·£µå º¼·ë  
±³À°ÁÖÁ¦ : 2019³â Ãá°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÃé´ãµµÇÐȸ
´ã´çÀÚ : ¼ÛÀç¼ø
¿¬¶ôó : 02-2285-5145  
À̸ÞÀÏ : kpba@kams.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 11 ½Ã°£ 55ºÐ  
¼¼ºÎ¼ö°­·á : 80,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë A 09:00~09:20 Recent updates of surgical and molecular pathology  Àå±âÅÃ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë A 09:20~09:40 Radiologic evaluation and differential diagnosis  ¹Ú¹Ì¼÷(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë A 09:40~10:00 EUS-based approach: diagnosis and ablation  ÀÌ»óÇù(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë A 10:00~10:20 Indication of surgery and postsurgical follow-up strategy  ÀÌÀçÈÆ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë B 09:00~09:20 Evaluation of patients suspected of common bile duct stone  À±ÀçÈÆ(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë B 09:20~09:40 Endoscopic sphincterotomy, balloon stone extraction, and basket stone extraction  À强ÀÏ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë B 09:40~10:00 EPBD/EPLBD  Á¤¼®(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë B 10:00~10:20 When the going gets tough: utilization of SpyGlass, peroral cholangioscopy, or drainage followed by stone removal  ¿ÀÄ¡Çõ(°æÈñÀÇ´ë) 
±³À°½Ã°£ 04-27  10:20~10:40 Coffee Break  () 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë A 10:40~11:00 The role of EUS in the early detection of pancreatic cancer  ¼ÛÅÂÁØ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë A 11:00~11:20 Advances in peroral cholangioscopy and EUS for indeterminate bile duct lesions  ÀÌÀ±³ª(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë A 11:20~11:40 The role of EUS in the differential diagnosis of polypoid lesions of the gallbladder: update  Ãµ¿µ±¹(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë A 11:40~12:00 EUS-guided tissue acquisition in the era of personalized medicine  ¹æ½Â¹Î(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë B 10:40~11:05 Clinical applications of liquid biopsies in patients with pancreatic cancer  ±èµ¿¿í(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë B 11:05~11:30 Conducting clinical research as a visiting scholar: merits and limitations  ÇöÁ¾Áø(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë B 11:30~11:55 Preclinical models as useful tools for the research and development of pancreatobiliary medical devices  ±ÇâÀÏ(Â÷ÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë 12:00~13:00 Lunch  () 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë A 13:00~13:20 Management algorithm of pancreatic calculi  À嵿±â(µ¿±¹ÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë A 13:20~13:40 Endoscopic management of pancreatobiliary stricture  Á¶ÀçÈñ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë A 13:40~14:00 Management of pain, exocrine and endocrine insufficiency  ÀüÅÂÁÖ(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë A 14:00~14:20 Case-based discussion  ³²Çü¼®(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë B 13:00~13:40 Oral Presentation 1  À̵¿±â, ±èÁ¾Çõ(¿¬¼¼ÀÇ´ë, ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë B 13:40~14:20 Oral Presentation 2  ¹Ú¼±¹Ì, ÁÖ±¤·Î(ÃæºÏÀÇ´ë, °æÈñÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë A 14:40~15:00 Radiation safety  ¼Õº´°ü(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë A 15:00~15:20 Physician burnout  Á¤¼®ÈÆ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë A 15:20~15:40 Musculoskeletal problems  ÀÌÁØÇà(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë A 15:40~16:00 Medicolegal issues  ÇÑÁ¤È£(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë B 14:40~15:00 Chemotherapy: knowing when to start, evaluate for response, and stop  ÀÌÈñ½Â(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë B 15:00~15:20 Optimal treatment sequence among various combinations  È²ÁøÇõ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë B 15:20~15:40 Optimal management of chemotherapy-related adverse events  Á¤¹Î±Ô(°æºÏÀÇ´ë) 
±³À°½Ã°£ 04-27 ±×·£µåº¼·ë B 15:40~16:00 Advances in systemic chemotherapy: novel agents  ¹ÚÁÖ°æ(¼º±Õ°üÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÃé´ãµµÇÐȸ 2019³â Ãá°èÇмú´ëȸ : 2019-04-27""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼¼ºê¶õ½ºº´¿ø ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ IGET Live Symposium 2019 : 2019-04-27
´ÙÀ½±Û ÇѸ²´ëÇб³¼º½Éº´¿ø °³¿øÀǸ¦ À§ÇÑ Ã´Ãß ÁúȯÀÇ ÃֽŠÁö°ß : 2019-04-27
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 105 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 5 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 5 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 5 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 1 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 1 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 1 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 1 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 1 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 1 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 1 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 1 2024-05-27
20880 ¼­¿ï (¿Â¶óÀÎ) 2024 ¸¶Æ÷±¸ÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
20879 ¼­¿ï Á¦10ȸ ¿ëºÀÀÇÇÐȸ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷